Presenting
InnovaDerma
We are an ambitious and innovative business that is dedicated to delivering high-performance products across all of our brands in beauty, personal care and life sciences.
We extensively research and evaluate all our ingredients for effectiveness, performance and all our formulas are rigorously tested by a consumer panel. We use skin kind and naturally derived ingredients in our skin and hair care brands. In life sciences, all our products are tested rigorously and meet stringent regulatory standards. We are passionate about science and creating ground breaking innovations that meet our very high standards, and those of our customers.
Jadestone Energy
Jadestone Energy plc is an independent oil and gas company focused on the Asia-Pacific region. It has a balanced and increasingly diversified portfolio of production and development assets in Australia, Malaysia, Indonesia, Thailand and Vietnam, all stable jurisdictions with a positive upstream investment climate. Led by an experienced management team with a track record of delivery, who were core to the successful growth of Talisman Energys business in Asia-Pacific, the Company is pursuing a strategy to grow and diversify the Companys production base both organically, through developments such at Akatara in Indonesia and Nam Du/U Minh in Vietnam, as well as through acquisitions that fit within Jadestones financial framework and play to the Companys strengths in managing maturing oil assets. Jadestone delivers value in its acquisition strategy by enhancing returns through operating efficiencies, cost reductions and increased production through further investment.
Mobile Streams
Mobile Streams (MOS) Mobile Streams PLC is engaged in the sale of mobile content through Multi-National Organisations, the sale of mobile content over the internet and the provision of consulting and technical services.
Open Orphan
Open Orphan (ORPH) is a rapidly growing niche CRO pharmaceutical services company which is the world leader in testing vaccines and antivirals through the use of human challenge clinical trials. Open Orphan is actively involved in the fight against COVID-19.
